Effect of glucagon and its 1-23 peptide fragment on lipolysis in isolated rat and human fat cells. 1976

P Mitznegg, and W Domschke, and S Domschke, and W Sprügel, and C J Estler, and E Wünsch, and E Jaeger, and L Demling

UI MeSH Term Description Entries
D008053 Lipid Mobilization LIPOLYSIS of stored LIPIDS in the ADIPOSE TISSUE to release FREE FATTY ACIDS. Mobilization of stored lipids is under the regulation of lipolytic signals (CATECHOLAMINES) or anti-lipolytic signals (INSULIN) via their actions on the hormone-sensitive LIPASE. This concept does not include lipid transport. Lipid Mobilizations,Mobilization, Lipid,Mobilizations, Lipid
D008297 Male Males
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

P Mitznegg, and W Domschke, and S Domschke, and W Sprügel, and C J Estler, and E Wünsch, and E Jaeger, and L Demling
August 1970, Archives internationales de pharmacodynamie et de therapie,
P Mitznegg, and W Domschke, and S Domschke, and W Sprügel, and C J Estler, and E Wünsch, and E Jaeger, and L Demling
January 1968, Pharmacology,
P Mitznegg, and W Domschke, and S Domschke, and W Sprügel, and C J Estler, and E Wünsch, and E Jaeger, and L Demling
May 1988, Biochemical and biophysical research communications,
P Mitznegg, and W Domschke, and S Domschke, and W Sprügel, and C J Estler, and E Wünsch, and E Jaeger, and L Demling
September 1969, The Journal of pharmacy and pharmacology,
P Mitznegg, and W Domschke, and S Domschke, and W Sprügel, and C J Estler, and E Wünsch, and E Jaeger, and L Demling
July 1969, Metabolism: clinical and experimental,
P Mitznegg, and W Domschke, and S Domschke, and W Sprügel, and C J Estler, and E Wünsch, and E Jaeger, and L Demling
May 1970, Canadian journal of physiology and pharmacology,
P Mitznegg, and W Domschke, and S Domschke, and W Sprügel, and C J Estler, and E Wünsch, and E Jaeger, and L Demling
January 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
P Mitznegg, and W Domschke, and S Domschke, and W Sprügel, and C J Estler, and E Wünsch, and E Jaeger, and L Demling
October 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
P Mitznegg, and W Domschke, and S Domschke, and W Sprügel, and C J Estler, and E Wünsch, and E Jaeger, and L Demling
October 1969, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
P Mitznegg, and W Domschke, and S Domschke, and W Sprügel, and C J Estler, and E Wünsch, and E Jaeger, and L Demling
January 1988, European journal of pharmacology,
Copied contents to your clipboard!